| Primary Dermal Microvascular Endothelial Cells; Normal, Human, Neonatal |
| Biosafety Level: | 1 |
| frozen |
| Homo sapiens (human) |
| Neonatal foreskin |
| Adherent |
| Neonatal |
| Cobblestone appearance with large dark nuclei; during proliferation, cells are small and evenly sized, display a high mitotic index and show no presence of smooth muscle cells. |
| 1 ml |
| In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location. |
| Vascular Cell Basal Medium (ATCC PCS-100-030)
Microvascular Endothelial Cell Growth Kit-BBE (ATCC PCS-110-040)
Microvascular Endothelial Cell Growth Kit-VEGF (ATCC PCS-110-041)
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC 30-2200)
Trypsin-EDTA for Primary Cells (ATCC PCS-999-003)
Trypsin Neutralizing Solution (ATCC PCS-999-004)
Gentamicin-Amphotericin B Solution (ATCC PCS-999-025)
Penicillin-Streptomycin-Amphotericin B Solution (ATCC PCS-999-002)
Phenol Red (ATCC PCS-999-001) |
| See Product Information Sheet |
| Drug screening, angiogenesis, oncology, inflammation, intercellular communication |
| ≥ 50% |
| ≥ 15 in complete growth medium |
| Bacteria and Yeast: Negative
Mycoplasma: Negative |
| Cells are von Willebrand factor positive and smooth muscle α-actin negative.
|
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.